secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001213900-24-069036
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne Q3 product rev up 31% to $826K; net loss narrows to $2.8M; oneRF partnership term sheet signed
--------------------------------------------------------------------------------

- Product revenue $826K in Q3 FY2024 vs $630K in Q3 FY2023 (+31%); net loss $2.8M vs $3.5M.
- Cash and equivalents $1.6M at June 30, 2024; subsequent $2.65M private placement and $3M credit facility in Aug 2024.
- Non-binding term sheet with undisclosed global medtech company to distribute OneRF Ablation System.
- First OneRF ablation cases completed; CMS granted new ICD-10-PCS code effective Oct 1, 2024.
- Operating expenses reduced to $3.1M from $3.8M YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024069036/0001213900-24-069036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024069036/ea0211181-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-069036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer